Alicja Nowaczyk
Overview
Explore the profile of Alicja Nowaczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zietal K, Mirowska-Guzel D, Nowaczyk A, Blecharz-Klin K
Planta Med
. 2024 Sep;
90(13):976-991.
PMID: 39265629
Traditional medicine has long recognized the therapeutic potential of , and recent scientific research has shed light on the pharmacological properties of this plant. The bioactive compounds that can be...
2.
Witczynska A, Alaburda A, Grzesk G, Nowaczyk J, Nowaczyk A
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203440
Dysrhythmia is a term referring to the occurrence of spontaneous and repetitive changes in potentials with parameters deviating from those considered normal. The term refers to heart anomalies but has...
3.
Stielow M, Witczynska A, Kubryn N, Fijalkowski L, Nowaczyk J, Nowaczyk A
Molecules
. 2023 Dec;
28(24).
PMID: 38138529
Drug bioavailability is a crucial aspect of pharmacology, affecting the effectiveness of drug therapy. Understanding how drugs are absorbed, distributed, metabolized, and eliminated in patients' bodies is essential to ensure...
4.
Jakimiuk A, Piechal A, Wiercinska-Drapalo A, Nowaczyk A, Mirowska-Guzel D
Pharmacol Rep
. 2023 Aug;
75(5):1138-1151.
PMID: 37605102
The evaluation of dolutegravir based on available preclinical and clinical studies reveals a risk of central nervous system (CNS) disorders associated with long-term use of the drug. The available literature...
5.
Wolowiec L, Osiak J, Wolowiec A, Wijata A, Grzesk E, Kozakiewicz M, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839644
Dyslipidemia is listed among important cardiovascular disease risk factors. Treating lipid disorders is difficult, and achieving desirable levels of LDL-cholesterol (LDL-C) is essential in both the secondary and primary prevention...
6.
Grzesk G, Witczynska A, Weglarz M, Wolowiec L, Nowaczyk J, Grzesk E, et al.
Molecules
. 2023 Jan;
28(2).
PMID: 36677920
Endogenous nitric oxide (NO)-dependent vascular relaxation plays a leading role in the homeostasis of the cardiovascular, pulmonary, and vascular systems and organs, such as the kidneys, brain, and liver. The...
7.
Fijalkowski L, Skubiszewska M, Grzesk G, Koech F, Nowaczyk A
Molecules
. 2022 Dec;
27(23).
PMID: 36500502
Acetylsalicylic acid (ASA) is one of the first drugs to be obtained by synthesis while being the most used. It has experienced the longest lasting commercial success and is considered...
8.
Nowaczyk A, Szwedowski D, Dallo I, Nowaczyk J
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35163488
Osteoarthritis (OA) can be defined as the result of pathological processes of various etiologies leading to damage to the articular structures. Although the mechanism of degenerative changes has become better...
9.
Kowalska M, Fijalkowski L, Nowaczyk A
Int J Mol Sci
. 2021 Jul;
22(12).
PMID: 34208199
Thus far, many hypotheses have been proposed explaining the cause of depression. Among the most popular of these are: monoamine, neurogenesis, neurobiology, inflammation and stress hypotheses. Many studies have proven...
10.
Kowalska M, Fijalkowski L, Kubacka M, Salat K, Grzesk G, Nowaczyk J, et al.
Molecules
. 2021 Jul;
26(12).
PMID: 34207748
Tiagabine is an antiepileptic drug used for the treatment of partial seizures in humans. Recently, this drug has been found useful in several non-epileptic conditions, including anxiety, chronic pain and...